doxorubicin hydrochloride
NDC 68001-706, doxorubicin hydrochloride, injection, suspension, liposomal, from BluePoint Laboratories.
- Product NDC
- 68001-706
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219199
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXORUBICIN HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-706-36 | 68001070636 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-706-36) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/55889588-c5f1-d9bc-e063-6294a90a5791
Use it
Look up 68001-706 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-706. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.